Phase II Investigation of Antimycobacterial Therapy on Progressive, Pulmonary Sarcoidosis

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified January 2014 by Vanderbilt University
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Wonder Drake, Vanderbilt University
ClinicalTrials.gov Identifier:
NCT02024555
First received: December 26, 2013
Last updated: January 15, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: May 2017
  Estimated Primary Completion Date: March 2017 (Final data collection date for primary outcome measure)